Your browser doesn't support javascript.
loading
Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasound.
Diekhoff, Torsten; Fischer, Thomas; Schefer, Quirino; Posch, Maximilian Georg; Dörner, Thomas; Laurent, Didier; Li, Yue; Wagner, Frank D; Oliver, Stephen John.
  • Diekhoff T; Institute for Radiology, Charité University Hospital, Berlin, Germany.
  • Fischer T; Institute for Radiology, Charité University Hospital, Berlin, Germany.
  • Schefer Q; Charité Research Organisation, Berlin, Germany.
  • Posch MG; Charité Research Organisation, Berlin, Germany.
  • Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany.
  • Laurent D; Novartis Pharma AG, Basel, Switzerland.
  • Li Y; Novartis Pharma AG, Basel, Switzerland.
  • Wagner FD; Charité Research Organisation, Berlin, Germany.
  • Oliver SJ; Novartis Pharma AG, Basel, Switzerland. stephen.oliver@novartis.com.
Clin Exp Rheumatol ; 38 Suppl 126(4): 228-236, 2020.
Article en En | MEDLINE | ID: mdl-33095139
Search on Google
Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Síndrome de Sjögren / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article